Personalized medicine: evolution, applications, challenges, and future directions
Keywords:
Personalized Medicine, Genomics, Pharmacogenomics, Precision Oncology, Digital Health, Health Equit.Abstract
Background: Personalized medicine represents a paradigm shift from population-based toward individualized, data-driven clinical practice, accelerated by genomics, next-generation sequencing, and artificial intelligence.
Objective: To examine the developmental trajectory, scientific foundations, research domains, ethical considerations, and implementation challenges of personalized medicine.
Methods: A narrative review synthesizing literature across genomics, pharmacogenomics, precision oncology, proteomics, biomarker diagnostics, and AI-assisted clinical decision support.
Results: Genomic medicine and pharmacogenomics optimize therapeutic selection while reducing adverse reactions. Precision oncology utilizes molecular tumour profiling for targeted therapy. AI-assisted decision support enhances real-time treatment personalization. However, clinical adoption is constrained by high costs, inadequate infrastructure, workforce skill gaps, and complex data interpretation. Ethical concerns include genetic privacy, discrimination risk, and health equity disparities, with significant implementation gaps persisting between high- and low-income regions.
Conclusions: Personalized medicine has become a cornerstone of contemporary healthcare. Sustainable integration requires robust regulatory frameworks, expanded education, cost-reduction strategies, and international collaboration to ensure equitable global access.
References
D. Giansanti, 'The future of healthcare is digital: Unlocking the potential of mobile health and E-health solutions', Healthcare (Basel), vol. 13, no. 7, p. 802, Apr. 2025. doi.org/10.3390/healthcare13070802
G. Molla and M. Bitew, 'Revolutionizing personalized medicine: Synergy with multi-omics data generation, main hurdles, and future perspectives', Biomedicines, vol. 12, no. 12, p. 2750, Nov. 2024. doi.org/10.3390/biomedicines12122750
V. Subbiah, 'The next generation of evidence-based medicine', Nat. Med., vol. 29, no. 1, pp. 49-58, Jan. 2023. doi.org/10.1038/s41591-022-02160-z
S. Deepta Saha, 'Exploring the building blocks of life: The human genome project, its impact in todays world', Int. J. Adv. Res. (Indore), vol. 11, no. 07, pp. 423-425, July 2023. doi.org/10.21474/IJAR01/17245
L. Marques et al., 'Advancing precision medicine: A review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare', Pharmaceutics, vol. 16, no. 3, p. 332, Feb. 2024. doi.org/10.3390/pharmaceutics16030332
A. Khan et al., 'Genomic medicine and personalized treatment: a narrative review', Ann. Med. Surg. (Lond.), vol. 87, no. 3, pp. 1406-1414, Mar. 2025. doi.org/10.1097/MS9.0000000000002965
R. Qahwaji, I. Ashankyty, N. S. Sannan, M. S. Hazzazi, A. A. Basabrain, and M. Mobashir, 'Pharmacogenomics: A genetic approach to drug development and therapy', Pharmaceuticals (Basel), vol. 17, no. 7, p. 940, July 2024. doi.org/10.3390/ph17070940
R. Ghai et al., 'Role of personalized medicine in clinical practice: An overview of current and future perspectives', Biomed. Pharmacol. J., vol. 17, no. 4, pp. 2111-2133, Dec. 2024. doi.org/10.13005/bpj/3011
M. A. Malki and E. R. Pearson, 'Drug-drug-gene interactions and adverse drug reactions', Pharmacogenomics J., vol. 20, no. 3, pp. 355-366, June 2020. doi.org/10.1038/s41397-019-0122-0
A. K. Srivastav, M. K. Mishra, J. W. Lillard Jr, and R. Singh, 'Transforming pharmacogenomics and CRISPR gene editing with the power of artificial intelligence for precision medicine', Pharmaceutics, vol. 17, no. 5, p. 555, Apr. 2025. doi.org/10.3390/pharmaceutics17050555
F. Marques-Garcia and C. Martinez-Bravo, 'A review of pharmacogenomics in the individualization of pharmacological treatment: present and future', J. Lab. Precis. Med., vol. 11, pp. 6-6, Jan. 2026. doi.org/10.21037/jlpm-25-9
M. Jamalinia and R. Weiskirchen, 'Advances in personalized medicine: translating genomic insights into targeted therapies for cancer treatment', Ann. Transl. Med., vol. 13, no. 2, p. 18, Apr. 2025. doi.org/10.21037/atm-25-34
M. F. Mercogliano, S. Bruni, F. L. Mauro, and R. Schillaci, 'Emerging targeted therapies for HER2-positive breast cancer', Cancers (Basel), vol. 15, no. 7, p. 1987, Mar. 2023. doi.org/10.3390/cancers15071987
D. Qiao, R. C. Wang, and Z. Wang, 'Precision oncology: Current landscape, emerging trends, challenges, and future perspectives', Cells, vol. 14, no. 22, p. 1804, Nov. 2025. doi.org/10.3390/cells14221804
E. J. Topol, 'High-performance medicine: the convergence of human and artificial intelligence', Nat. Med., vol. 25, no. 1, pp. 44-56, Jan. 2019. doi.org/10.1038/s41591-018-0300-7
K. B. Johnson et al., 'Precision medicine, AI, and the future of personalized health care', Clin. Transl. Sci., vol. 14, no. 1, pp. 86-93, Jan. 2021. doi.org/10.1111/cts.12884
A. Mishra, A. Majumder, D. Kommineni, C. Anna Joseph, T. Chowdhury, and S. K. Anumula, 'Role of generative artificial intelligence in personalized medicine: A systematic review', Cureus, vol. 17, no. 4, p. e82310, Apr. 2025. doi.org/10.7759/cureus.82310
H. Taherdoost and A. Ghofrani, 'AI's role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy', Intelligent Pharmacy, vol. 2, no. 5, pp. 643-650, Oct. 2024. doi.org/10.1016/j.ipha.2024.08.005
D. Giansanti, 'Precision medicine 2.0: How digital health and AI are changing the game', J. Pers. Med., vol. 13, no. 7, p. 1057, June 2023. doi.org/10.3390/jpm13071057
A. L. McGuire et al., 'Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider', Genet. Med., vol. 10, no. 7, pp. 495-499, July 2008. doi.org/10.1097/GIM.0b013e31817a8aaa
G. J. Schumacher, S. Sawaya, D. King, and A. J. Hansen, 'Genetic information insecurity as state of the art', Front. Bioeng. Biotechnol., vol. 8, no. 591980, p. 591980, Dec. 2020. doi.org/10.3389/fbioe.2020.591980
N. E. Kass et al., 'Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions', Am. J. Med. Genet. A, vol. 143A, no. 7, pp. 707-717, Apr. 2007. doi.org/10.1002/ajmg.a.31576
L. H. Seaver et al., 'Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG)', Genet. Med., vol. 24, no. 3, pp. 512-520, Mar. 2022. doi.org/10.1016/j.gim.2021.11.002
K. K. Y. Francisco et al., 'Personalized medicine and health equity: overcoming cost barriers and ethical challenges', Int. J. Equity Health, vol. 25, no. 1, p. 4, Dec. 2025. doi.org/10.1186/s12939-025-02710-0
G. S. Ginsburg and K. A. Phillips, 'Precision medicine: From science to value', Health Aff. (Millwood), vol. 37, no. 5, pp. 694-701, May 2018. doi.org/10.1377/hlthaff.2017.1624
D. E. Pritchard, F. Moeckel, M. S. Villa, L. T. Housman, C. A. McCarty, and H. L. McLeod, 'Strategies for integrating personalized medicine into healthcare practice', Per. Med., vol. 14, no. 2, pp. 141-152, Mar. 2017. doi.org/10.2217/pme-2016-0064
K. Schwarze, J. Buchanan, J. C. Taylor, and S. Wordsworth, 'Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature', Genet. Med., vol. 20, no. 10, pp. 1122-1130, Oct. 2018. doi.org/10.1038/gim.2017.247
S. Mani, S. R. Lalani, and M. Pammi, 'Genomics and multiomics in the age of precision medicine', Pediatr. Res., vol. 97, no. 4, pp. 1399-1410, Mar. 2025.doi.org/10.1038/s41390-025-04021-0
M. Edvardsson and M. K. Heenkenda, 'Precision medicine: Personalizing healthcare by bridging aging, genetics, and global diversity', Healthcare (Basel), vol. 13, no. 13, p. 1529, June 2025. doi.org/10.3390/healthcare13131529
N. J. Schork, 'Randomized clinical trials and personalized medicine: A commentary on deaton and cartwright', Soc. Sci. Med., vol. 210, pp. 71-73, Aug. 2018. doi.org/10.1016/j.socscimed.2018.04.033
L. Sbitan, N. Alzraikat, H. Tanous, A. M. Saad, and M. Odeh, 'From one size fits all to a tailored approach: integrating precision medicine into medical education', BMC Med. Educ., vol. 25, no. 1, p. 90, Jan. 2025. doi.org/10.1186/s12909-024-06138-y
D. J. Duffy, 'Problems, challenges and promises: perspectives on precision medicine', Brief. Bioinform., vol. 17, no. 3, pp. 494-504, May 2016. doi.org/10.1093/bib/bbv060
S. F. Terry, 'Obama's precision medicine initiative', Genet. Test. Mol. Biomarkers, vol. 19, no. 3, pp. 113-114, Mar. 2015. doi.org/10.1089/gtmb.2015.1563
I. D. Gray, A. R. Kross, M. E. Renfrew, and P. Wood, 'Precision medicine in lifestyle medicine: The way of the future?', Am. J. Lifestyle Med., vol. 14, no. 2, pp. 169-186, Mar. 2020. doi.org/10.1177/1559827619834527
E. Juengst, M. L. McGowan, J. R. Fishman, and R. A. Settersten Jr, 'From "personalized" to "precision" medicine: The ethical and social implications of rhetorical reform in genomic medicine', Hastings Cent. Rep., vol. 46, no. 5, pp. 21-33, Sept. 2016. doi.org/10.1002/hast.614
C. Delpierre and T. Lefe vre, 'Precision and personalized medicine: What their current definition says and silences about the model of health they promote. Implication for the development of personalized health', Front. Sociol., vol. 8, p. 1112159, Feb. 2023. doi.org/10.3389/fsoc.2023.1112159
L. H. Xu, H. Zheng, D. D. Sedmak, and W. Sade e, 'The re-emerging concept of personalized healthcare', Per. Med., vol. 5, no. 5, pp. 457-469, Sept. 2008. doi.org/10.2217/17410541.5.5.457
V. Subbiah, 'The next generation of evidence-based medicine', Nat. Med., vol. 29, no. 1, pp. 49-58, Jan. 2023. doi.org/10.1038/s41591-022-02160-z
M. A. Hamburg and F. S. Collins, 'The path to personalized medicine', N. Engl. J. Med., vol. 363, no. 4, pp. 301-304, July 2010 doi.org/10.1056/NEJMp1006304
R. A. Gibbs, 'The Human Genome Project changed everything', Nat. Rev. Genet., vol. 21, no. 10, pp. 575-576, Oct. 2020. doi.org/10.1038/s41576-020-0275-3
Fang Z. Pharmacogenomics: Enhancing Therapeutic Efficacy and Quality Care through Genetic Information. Longdom [Internet]. 2024 Jul 2; Available from: doi.org/10.35248/2161-1025.24.14.320
R. Colomer et al., 'Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement', EClinicalMedicine, vol. 60, no. 102029, p. 102029, June 2023. doi.org/10.1016/j.eclinm.2023.102029
A. A. Durmaz, E. Karaca, U. Demkow, G. Toruner, J. Schoumans, and O. Cogulu, 'Evolution of genetic techniques: past, present, and beyond', Biomed Res. Int., vol. 2015, p. 461524, Mar. 2015. doi.org/10.1155/2015/461524
W. Liu et al., 'The 1% gift to humanity: The Human Genome Project II', Cell Res., vol. 34, no. 11, pp. 747-750, Nov. 2024. doi.org/10.1038/s41422-024-01026-y
U. M. Zanger and M. Schwab, 'Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation', Pharmacol. Ther., vol. 138, no. 1, pp. 103-141, Apr. 2013. doi.org/10.1016/j.pharmthera.2012.12.007
J. K. Hicks et al., 'Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors', Clin. Pharmacol. Ther., vol. 98, no. 2, pp. 127-134, Aug. 2015. doi.org/10.1002/cpt.147
A. C. Wolff et al., 'Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists guideline update', J. Clin. Oncol., vol. 41, no. 22, pp. 3867-3872, Aug. 2023. doi.org/10.1200/JCO.22.02864
G. S. Ginsburg and K. A. Phillips, 'Precision medicine: From science to value', Health Aff. (Millwood), vol. 37, no. 5, pp. 694-701, May 2018. doi.org/10.1377/hlthaff.2017.1624
L. Piwek, D. A. Ellis, S. Andrews, and A. Joinson, 'The rise of consumer health wearables: Promises and barriers', PLoS Med., vol. 13, no. 2, p. e1001953, Feb. 2016. doi.org/10.1371/journal.pmed.1001953
D. K. Ming et al., 'Continuous physiological monitoring using wearable technology to inform individual management of infectious diseases, public health and outbreak responses', Int. J. Infect. Dis., vol. 96, pp. 648-654, July 2020. doi.org/10.1016/j.ijid.2020.05.086
D. A. Mrazek and C. Lerman, 'Facilitating clinical implementation of pharmacogenomics', JAMA, vol. 306, no. 3, pp. 304-305, July 2011. doi.org/10.1001/jama.2011.1010
H. N. Patel et al., 'Genomic medicine: Applications in disease prevention and treatment', J. Pharm. Bioallied Sci., vol. 17, no. Suppl 2, pp. S1101-S1103, June 2025. doi.org/10.4103/jpbs.jpbs_541_25
S. Zampatti, 'The revolution of genetic diagnosis: An example from rare disorders', Genes (Basel), vol. 15, no. 10, p. 1328, Oct. 2024. doi.org/10.3390/genes15101328
I. R. Watson, K. Takahashi, P. A. Futreal, and L. Chin, 'Emerging patterns of somatic mutations in cancer', Nat. Rev. Genet., vol. 14, no. 10, pp. 703-718, Oct. 2013. doi.org/10.1038/nrg3539
S. Al-Amrani, Z. Al-Jabri, A. Al-Zaabi, J. Alshekaili, and M. Al-Khabori, 'Proteomics: Concepts and applications in human medicine', World J. Biol. Chem., vol. 12, no. 5, pp. 57-69, Sept. 2021. doi.org/10.4331/wjbc.v12.i5.57
M. Celeski et al., 'The role of cardiac troponin and other emerging biomarkers among athletes and beyond: Underlying mechanisms, differential diagnosis, and guide for interpretation', Biomolecules, vol. 14, no. 12, p. 1630, Dec. 2024. doi.org/10.3390/biom14121630
C. Chen et al., 'Applications of multi-omics analysis in human diseases', MedComm, vol. 4, no. 4, p. e315, Aug. 2023. doi.org/10.1002/mco2.315
B. Liu, H. Zhou, L. Tan, K. T. H. Siu, and X.-Y. Guan, 'Exploring treatment options in cancer: Tumor treatment strategies', Signal Transduct. Target. Ther., vol. 9, no. 1, p. 175, July 2024. doi.org/10.1038/s41392-024-01856-7
E. A. Jafleh, F. A. Alnaqbi, H. A. Almaeeni, S. Faqeeh, M. A. Alzaabi, and K. Al Zaman, 'The role of wearable devices in chronic disease monitoring and patient care: A comprehensive review', Cureus, vol. 16, no. 9, p. e68921, Sept. 2024. doi.org/10.7759/cureus.68921
A. Haleem, M. Javaid, R. P. Singh, and R. Suman, 'Telemedicine for healthcare: Capabilities, features, barriers, and applications', Sens. Int., vol. 2, no. 100117, p. 100117, July 2021. doi.org/10.1016/j.sintl.2021.100117
P. Kumar, D. J. Benjamin, S. Darabi, G. Kloecker, and A. Rezazadeh Kalebasty, 'Implications of genetic testing and informed consent before and after genetic testing in individuals with cancer', World J. Clin. Oncol., vol. 15, no. 8, pp. 975-981, Aug. 2024. doi.org/10.5306/wjco.v15.i8.975
M. Martyn et al., 'Secondary use of genomic data: patients' decisions at point of testing and perspectives to inform international data sharing', Eur. J. Hum. Genet., vol. 32, no. 6, pp. 717-724, June 2024. doi.org/10.1038/s41431-023-01531-5
Published
How to Cite
Issue
Section
Copyright (c) 2026 Ravi Rai Dangi, Priya Naik, Sandarbh Vyas, Nikesh Kumar
This work is licensed under a Creative Commons Attribution 4.0 International License.
